AcetaZOLAMIDE



AcetaZOLAMIDE





(ah set a zole’ ah mide)

Apo-Acetazolamide (CAN), Diamox Sequels

PREGNANCY CATEGORY C


Drug Classes

Antiepileptic

Antiglaucoma drug

Carbonic anhydrase inhibitor

Diuretic

Sulfonamide (nonbacteriostatic)



Therapeutic Actions

Inhibits the enzyme carbonic anhydrase. This action decreases aqueous humor formation in the eye, IOP, and hydrogen ion secretion by renal tubule cells, and increases sodium, potassium, bicarbonate, and water excretion by the kidney, causing a diuretic effect. In epilepsy, carbonic anhydrase inhibition seems to retard abnormal, excessive discharge from CNS neurons.


Indications



  • Adjunctive treatment of chronic open-angle glaucoma, secondary glaucoma


  • Preoperative use in acute angle-closure glaucoma when delay of surgery is desired to lower IOP


  • Edema caused by heart failure, drug-induced edema


  • Centrencephalic epilepsy (absence, unlocalized seizures)


  • Prophylaxis and treatment of acute mountain sickness


  • Unlabeled uses: Malignant glaucoma, migraine prevention, familial periodic paralysis, cystine or uric acid renal calculi prevention, tardive dyskinesia



Available Forms

Tablets—125, 250 mg; ER capsules—500 mg; powder for injection—500 mg/vial


Dosages

Adults

Jul 20, 2016 | Posted by in NURSING | Comments Off on AcetaZOLAMIDE

Full access? Get Clinical Tree

Get Clinical Tree app for offline access